Last reviewed · How we verify
PBGENE-HBV
At a glance
| Generic name | PBGENE-HBV |
|---|---|
| Sponsor | Precision BioSciences, Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
- Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PBGENE-HBV CI brief — competitive landscape report
- PBGENE-HBV updates RSS · CI watch RSS
- Precision BioSciences, Inc. portfolio CI